Vanguard Capital Management
COCH icon

Vanguard Capital Management’s Envoy Medical COCH Stock Holding History

Vanguard Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$697K Sell
880,214
-1,458
-0.2% -$990 ﹤0.01% 3657
2026
Q1 		$586K Buy
+881,672
New +$601K ﹤0.01% 3646

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Capital Management's COCH Position: Q2 2026 in Review

Vanguard Capital Management reduced its Envoy Medical (COCH) stake by 0.17% in Q2 2026, selling an estimated $990 and leaving 880,214 shares worth $697K. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

Vanguard Capital Management first reported a position in COCH in Q1 2026 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Vanguard Capital Management held 880,214 shares of Envoy Medical worth $697K as of Q2 2026.
  • Vanguard Capital Management sold 1,458 Envoy Medical shares in Q2 2026, an estimated $990.
  • Envoy Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3657 holding.
  • Vanguard Capital Management first reported a position in Envoy Medical in Q1 2026 and has held it in 2 quarters since.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.